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factors. RR of CV events is shown in the table. 
Conclusion: Current ERT use among older women was associated with fewer myocardial 
infarctions and "HERS endpoints", but there was no association with all cause mortality 
or stroke. Past ERT use was associated with lower all cause mortality, but there was no 
association with CV events. The observed associations may reflect a healthy-user effect. 
Clinical trials will be necessary to assess the effect of ERT in older women. 
Fully Adjusted Cox Model of CV Events (RR(95%Cl)) 
Past ERT Current ERT 
Death .72 (.57,.90) 1.03 (.76,1.40) 
Myocardial Infarction ,90 (,66,1.23) .44 (.23,.84) 
Stroke ,84 (.62,1,13) .94 (.60,1.45) 
"HERS Endpoint" (nonfatal MI or CHD death) .82 (.64,1.06) .54 (.34.86) 
1113-150 Chron ic  V i tamin C Supplementation Improves 
Endothelial Function in Diabetic Pat ients  With Coronary  
Ar tery  Disease 
Charalambos Antoniades. Dimltris Tousoulis, Costas Tentolouris, Kyriakoula Marinou, 
Athanasios Trikas, Stella Brilii, Christos Pitsavos. Christodoulos Stefanadis, Pavlos 
Toutouzas, Cardiology Unit, Hippokration Hospital, Athens University Medical School, 
Athens, Greece. 
Background: Coronary artery disease (CAD) as well as diabetes mellltus (DM), are both 
known to be associated with endothelial dysfunction. Oxidative stress is considered to be 
one of the most important mechanisms involved in the pathogenesis of endothelial dysfunc- 
tion in CAD and DM. In this study we investigated whether treatment with the antioxidant 
vitamin C improves endothelial function in patients with type ~ or II DM and CAD. 
Methods: In a double-blind placebo-controlled study, 48 patients (42 males, 6 females, aged 
66±1.3 years) with CAD and DM, were enrolled. 22 of them were of type I DM and 26 of type 
I1.18 diabetic patients (7 with type I DM (group A) and 11 with type II DM (group B)) were 
treated with vitamin C 2g/day for 4 weeks. The remaining (15 with type I DM (group C) and 
15 with type II DM (group D)) received placebo for 4 weeks. Forearm blood flow was mea- 
sured using venous occlusion strain-gauge plethysmography, at baseline and after treat- 
ment. Endothelium dependent flow mediated vasodilation (FMD) was expressed as the % 
change from baseline to post reactive hyperemia blood flow. Endothelium independent flow 
(NTG%) was expressed as the % change from baseline to pest sublingual nitroglycerin 
administration flow. 
Results: Baset blood pressure, heart rate, body weight, basal forearm blood flow and NTG% 
remained unchanged in all groups. All values are expressed as msan±SEM. FMD was sim- 
ilar between patients with type I (53.9±3.3%) and type II (57.8±6.0%, p=NS) DM. After treat- 
ment, RH% was significantly increased in groups A (from 54.2±7.3 to 73.1±7.1% p<0.05) 
and B (from 66.5±11.7 to 84.3±15.1% p<0.05) while remained unchanged in groups C (from 
53.1 ±4.2 to 50,1 ±8.2% p=NS) and D (from 55.8±11.6 to 58.3±10.1% p=NS). 
Conclusions: Chronic administration of vitamin C seems to improve endothelial function in 
patients with combined coronary artery disease and diabetes mellitus of type I or II. These 
findings indicate a possible beneficial role of antioxidant vitamin C in diabetic patients with 
coronary artery disease. 
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830FO-2 The Yield of  Screening Stress Myocardial Perfusion 
Imaging in Asymptomatic Diabetics 
Todd D. Miller. Navin Rajagopalan, David O. Hodge, Robert L Frye, Raymond J. 
Gibbons, Mayo Clinic, Rochester, Minnesota. 
Background: Diabetics have a higher prevalence of silent coronary artery disease 
(CAD) than nondiabetics and a prognosis similar to that of patients with established CAD. 
Nonetheless, screening stress testing in asymptomatic persons without known CAD 
including diabetics is not well established according to the ACC/AHA Guidelines for Exer- 
cise Testing. 
Methods: The results of exercise and pharmacologic single photon emission computed 
tomography (SPECT) imaging were analyzed in 27,179 patients without known CAD who 
underwent testing between January 1986 and December 2000. Patients were grouped 
by symptom and diabetes status. SPECT scans were categorized as abnormal or not 
and "high-dsk" (on the basis of previously published critaria) or not. 
Results: 
Subset Number Age Male (%) Abnormal High-risk 
(yrs_+ SD) SPECT (%) SPECT (%) 
Symptomatic, nondiabetic 16,196 62_+15" 53* 44* 13" 
Symptomatic, diabetic 2994 63_+11" 53* 59 22 
Asymptomatic, nondiabetic 6248 63_+11 * 73* 46* 11 * 
Asymptomatic, diabetic 1741 60~__13 70 59 20 
• p _< 0.004 vs asymptomatic diabetic 
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Insulin use did not further stratify asymptomatic diabetics for abnormal SPECT (57% 
insulin vs 60% no insulin, p=0.15) or high-dsk SPECT images (20% insulin vs 19% no 
insulin, p=0,59). In asymptomatic diabetics who underwent exercise stress (52%), a pos- 
itive ECG occurred in 29%. 
Conclusions: In asymptomatic patients referred for screening stress SPECT imaging, 
diabetics are slightly younger and more frequently female than nondiabetics but have a 
significantly higher prevalence of abnormal and high-risk SPECT scans. Both abnormal 
and high-risk scans are more common in asymptomatic diabetics than even in symptom- 
atic nondiabetics. 
2:30 p.m. 
830FO-3 Compar i son  of  Noninvaslve Cardiac Testing in 903 
Asymptomatic Men: Corre lat ion With Coronary  
Angiography and With Cl inical  Events  st  Two and Five 
Years 
Patrick J. Fitzsimmons. Ants Palm-Leis, William T. Thompson, William B. Kruyer, USAF 
School of Aerospace Medicine, Brooks AFB, Texas. 
Background: Noninvasive techniques may be used to screen asymptomatic subjects for 
coronary artery disease (CAD). However, the accuracy of these tests is significantly influ- 
enced by the low prevalence of CAD in asymptomatic populations. We sought to define 
the accuracy of three noninvasive tests for predicting significant CAD and cardiac events 
in a population of asymptomatic men. 
Methods: From a database of 1487 asymptomatlc military aviators who had coronary 
angiography performed for occupational indications and had clinical follow-up, we identi- 
fied 903 who had all three noninvasive tests prior to angiography - treadmill, stress thal- 
lium imaging and coronary artery fluoroscopy for detection of coronary calcification. 
Sensitivity, specificity and positive and negative predictive values were calculated for 
each test for the presence of significant CAD (maximum lesion >50% stenosis). Cardiac 
event rates at two and five years were determined for abnormal versus normal test. Car- 
diac events considered were cardiac death, nonfatal myocardial infarction and coronary 
revascularization. 
Results: Mean age at coronary angiography was 43.7 (+/-6.2) years and mean follow-up 
was 11.8 (+/-3.8) years. Sensitivity, specificity and positive and negative predictive values 
for the presence of significant CAD were: treadmill 54%, 49%, 16% and 86%; thallium 
55%, 62%, 21% and 89%; and fluoroscopy 68%, 71%, 29% and 93%. Average annual 
cardiac event rates at two and five years for abnormal test were: abnormal treadmill 
1.0%/yr and 0.5%/yr, abnormal thanium 1.0%/yr and 0.6% /yr, and positive coronary 
artery fluoroscopy 1.6%/yr and 1.3%/yr. For normal test, event rates at two and five years 
were: normal treadmill 0.3%/yr and 0.5%/yr, normal thanium 0.5%/yr and 0.5%/yr, and 
negative fluoroscopy 0.2%/yr and 0.1%/yr, 
Conclusion: As expected, all three noninvasive tests were independently poor predictors 
of significant CAD and cardiac events in this low CAD prevalence population. For all 
parameters examined, detection of coronary calcification by routine fluoroscopy per- 
formed better than treadmill and thallium, both for prediction of anatomic disease and for 
cardiac events at two and five years of fonow-up. 
2:45 p.m. 
830FO-4 Ventrlcular Ectopic Activity Predicts Mortality When It 
Occurs During Recovery, but Not Just During Exercise 
Joseph Frolkis, Claire E. Pothier Snarler, Eugene H. Blackstone, Michael S. Lauer. 
Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: Ventdcular ectopy (VEA) induced by exercise predicts death in population- 
based cohorts. We examined the prognostic importance of VEA dudeg exercise and 
recovery, when reactivation of parasympathetic activity occurs. We hypothesized that 
VEA dudng recovery would predict death better than VEA during exemise. 
Methods: We followed for 5.3 years 28,976 patients (age 56+11, 70% male) who under- 
went treadmill exercise testing and were without heart failure, valve disease, atrial fibdlla- 
tion, VEA history, or pacemakers. VEA was defined as: > 7 VPCs/minuta, ventricular 
bigeminy or trigeminy, ventricular tachycardia, or veetricular fibdllation. 
Results: VEA during exercise only occurred in 923 patients (3%), during recovery only in 
577 (2%), and during exercise and recovery in 483 (2%). There were 1801 deaths (6%). 
In univariate analyses, VEA dudng exercise predicted death (11% vs. 6%, hazard ratio 
[HR] 1.9, 95% CI 1.6-2.2, P<0.0001), but VEA during recovery was a stronger predictor 
(13% vs. 6%, HR 2.4, 95% CI 2.1-2.9, P<0.0001) (Figure), 
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After accounting for age, gender, risk factors, medications, coronary history, exercise 
capacity, chronotropic response, and heart rate recovery, VEA during recovery remained 
predictive of death (adjusted HR 1.5, 95% CI 1.2-1.8, P<0.0001), but VEA during exer- 
cise was not predictive (adjusted HR 1.1, 95% CI 0.9-1.4, P--0.18).Concluelon: As we 
hypothesized, VEA during recovery after exercise predicts mortality, but VEA only during 
exercise does not. 
3:00 p.m. 
830FO-5 Exercise-Induced Ventricular Premature Beats Are 
Associated With Increased Cardiovascular Mortality: 
The Framingham Heart Study 
All Morshedi-Meibodi. Jane Evans, Daniel Levy, Martin G. Larson, Ramachandran 
Vasan, NHLBrs Framingham Heart Study, Framingham, Massachusetts, Boston 
University School of Medicine, Boston, Massachusetts. 
Background: There is controversy regarding the prognostic impact of exercise-induced 
ventricular premature beats (VPB). While eadier studies reported no adverse relation, the 
Paris Prospective Study recently reported an increase risk of death in men with exercise- 
induced VPBs. 
Methods: We evaluated 2,840 Framingham Offspring Study subjects (1,388 men, mean 
age 43 years) who were free of cardiovascular disease and underwent a heart rata-lim- 
fled exercise test according to the Bruce protocol during a routine examination. 780 sub- 
jects (27%) had VPBs during the exercise (median of 0.22 VPBs/minute of exercise). 
Subjects were divided into three groups based on the numbers of VPBs/minute of exer- 
cise: those without any VPBs, those below (low frequency VPBs) and those above the 
median (high frequency VPBs). Cox proportional hazard regression models incorporating 
established risk factors (age, sex, diabetes, hypertension, smoking, total and HDL cho- 
lesterol) and adjusting for interim cardiovascular disease (CVD) events were used to 
examine the association of exemise-induced VPBs at the baseline examination with risk 
of death due to coronary heart disease (CHD), CVD (including CHD and other vascular 
events), and all-cause mortality on follow up, 
Results: On follow up (mean 15 years), 159 subjects died (38 CVD deaths [31 men), 29 
CHD deaths [24 men]). Exercise-induced VPBs were associated with increased risk of 
all-cause mortality [multivarieble HR for trend across 3 groups of 1.38, 95% CI, 1.14- 
1.65], CHD-death (HR 1.82, 95% CI, 1.20-2.74] and CVD-death [HR 1.91, 95% CI, 1.33- 
2.73]. The high VPB frequency group was associated with the greatest risk of all three 
outcomes. 
Conclusions: In our large community-based sample of men and women, exercise- 
induced VPBs identified a group at increased sk of death secondary to CHD, CVD, and 
all-cause mortality. Additional studies are needed to examine the utility of the exercise- 
induced VPBs for risk stratification. 
3:15 p.m. 
830FO-6 Heart Rate Recovery Improved in a Cohort of Adults 
After Cardiac Rehabilitation 
Ema Obenza Nishime. Christopher R, Cole, Gregory S, Wallace, Robert J. Rosnick, 
Claire E. Pothier Snader, Eugene H. Blackstone, Gordon Blackburn, Michael S, Lauer, 
Cleveland Clinic Foundation, Cleveland, Ohio. 
Background: An abnormal heart rate recovery after exercise predicts mortality, As exer- 
cise modulates autonomic function and heart rate recovery reflects vagal tone, we 
hypothesized that cardiac rehabilitation would favorably impact heart rate recovery. 
Methods: Consecutive adults (n=595, 61_+11 years, 78% male) who underwent symp- 
tom-limited exercise tests before and after Phase II cardiac rehabilitation were studied. 
Heart rate recovery (HRR) was the difference of heart rate at peak exercise and one- 
minute later with _< 12 bpm abnormal. 
Results: HRR improved from a median of 13 bpm before rehabilitation to 17 bpm affer- 
wards (P<0.0001). There were 287 adults (48%) with abnormal baseline HRR; 161 
(56%) were still abnormal afterwards. Predictors of failure to improve HRR included older 
age (for 10 years, adjusted Odd Ratio [OR] 1.3, 95% CI 1.0-1.7, p=0.03), lesser change 
in exercise capacity (for 1.5 METs, adjusted OR 1.3, 95% CI 1,1-1.6, p=0.002). During 4 
years, there were 42 deaths. After adjusting for age, gender, and change in exercise 
capacity, abnormal baseline HRR predicted eath (12% vs. 3%, adjusted HR 4.0, 95% CI 
1.8-8.8, p=0.0006). Failure to improve an abnormal HRR tended to predict higher mortal- 
ity (adjusted HR 2.0, 95% CI 0.9-4.3, P=0,08) (Figure). 
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Conclusion: Heart rate recovery improved in patients affer cardiac rehabilitation. 
Although we cannot exclude regression to the mean, the tendency of an improved HRR 
to predict lower mortality suggests that this was prognostically meaningful. 
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1133-137 Myocardial Overexpresaion of the Cardiac b-Adrenergic 
Receptor Kinaee-1 Inhibitor (BARKI) Delay the 
Development of Cardiomyopsthy Induced by 
Myocardial Expression of Monocyte Chemo-Tactic 
Protein-1 (MCP-1) 
Samer J. Khouri, Philip Binkley, Walter Koch, Pappechan Kolattukudy, Ohio State 
Universi~ Columbus, Ohio, Duke University, Durham, North Carolina. 
Background: Targeted expression of MCP-1 in the cardiomyocytes induces cardiomy- 
opathy in a murine model. We hypothesized that overexpression ofBARKI in these MCP- 
1 mice may delay the progression of ventricular remodeling. Methods: Studies were per- 
formed on mice with targeted myocardial expression of BARKI, MCP-1, BARKI and 
MCP-1 (MCP-BARKI) and wild-type mice as controls. 2D and M-mode echo were per- 
formed at baseline, 1 and 2 month. Results: At baseline MCP-1 and MCP-BARKI mice 
did not have a significant difference in mass 68.4 ± 0.6 & 68.6 ± 0.7 mg nor in EF 42 ± 5 
& 44 -+ 3 % and they were significantly different from BARKI mice and controls (Figures). 
The MCP-BARKI and MCP-1 mice increased LV mass to the same extent at one month. 
However, at two months, the LV mass was significantly greater in the MCP-1 mice as 
compared to MCP-BARKI mice 92.9 ± 83 and 80.0 ± 1.3 mg, respectively. BARKI and 
control mice had mild increase in cardiac mass, but significantly different from MCP-1 
and MCP-BARKI mice 69.9 + 0.4 and 70.9 + 1.7, respectively. The EF did not show sig- 
nificant change over time (figure 2). Conclusion: 13ARKI overexpression does not pre- 
serve myocardial contractility in mice with cardiomyopathy that express MCP-1, but has 
a significance ffect on the cardiac mass. This suggests a significant influence of BARKI 
overexpression i  preventing cardiac remodeling. This may suggest a novel molecular 
target for future therapies targeted at the prevention of progressive ventricular remodel- 
ing in patients with heart failure. 
1133-138 Down-Regulation of Sodium Current in Heart Failure: 
Rescue by Beta-Blockers 
AIbertas I. Undrovina~, Victor A. Maltsev, Hani N. Sabbah, Henry Ford Heart and 
Vascular institute, Detroit, Michigan. 
Background: Ion channel remodeling is believed to provide a substrate for ventdcular 
arrhythmias in heart failure (HF). We recently showed that Na + channels (NaCh) respon- 
sible for excitation generation and propagation i  the heart are down-regulated inchronic 
infarction-induced dog HF model, a feature that suggests possible involvement of these 
channels in ventdcular arrhythmias. While ~-blockers (BB) are known to significantly 
reduce the risk of the ventdcular arrhythmias and sudden cardiac death in patients with 
HF, the cellular and ionic mechanisms of this beneficial effect remain unknown. In this 
study, we tested the hypothesis that BB prevent NaCh downregulation i chronic HF. 
Methods: Studies were performed in cardiomyocytes isolated from dogs with chronic HF 
produced by multiple sequential intracoronary microembolizations. In addition to marked 
LV systolic and diastolic dysfunction, dogs with chronic HF also manifests pontaneous 
ventricular arrhythmias and sudden cardiac death occurs in -13% of HF animals. To 
study the effects of BB on the regulation NaCh, HF (LV ejection fraction 28±1%) was pro- 
duced in 12 dogs. Six HF dogs were treated for 3 months with carvedilol (1 mg/kg, twice 
daily) and 6 were untreated and sewed as controls. In addition, cardiomyocytes from 9 
normal dogs were used for comparison. At the end of 3 months of therapy, mid-myocar- 
dial cardiomyocytes were isolated from the LV free wall. The whole-cell maximum Na + 
current (INa) was measured using patch-clamp technique in symmetrical Na + solutions 
([Na]i=[Na]o=Smmol/L) at room temperature. Chronic treatment with carvedilol restored 
INa density in dogs with HF INa density in carvedilol dogs was significantly higher com- 
pared to that of untreated HF dogs (46.4:L-0.9 pNpF vs. 33±3.3 pNpF, P=0.008) and was 
similar to that of normal dogs (48.5±5.1 pNpF). The voltage dependence of steady-stats 
inactivation and activation of INa remained unchanged in both carvedilol-treated and 
untreated HF dogs. 
Conclusion: Down-regulation of NaCh in ventdcular cardiomyocytes caused by chronic 
HF in dog can be prevented by a chronic therapy with 13-blockers. 
